PARTNERSHIP FUND FOR NEW YORK CITY: "NEW YORK'S LIFE SCIENCES INDUSTRY".
Regular price $0.00Digital Report - immediate delivery to your email.
Date of Publishing: 2021
No. of Pages: 11
New York’s life sciences industry has performed exceptionally well during the COVID-19 pandemic and will be a significant source of new jobs and business formation as communities across New York City and state rebuild their economies in the wake of the pandemic. The success of New York-headquartered Pfizer and Regeneron in producing the first coronavirus vaccine and effective therapeutic treatments for the virus have highlighted the region’s emerging leadership in one of the world’s fastest-growing industries.
___________________________________________________________________________________________
Contents:
1. Private Investment into New York State Life Sciences.
2. Public Finding into New York State Life Sciences.
3. Ratio of Public to Private Investment.
4. Economic Impact.
5. Contribution to Gross City Product.
6. New Business Formation.
7. Employment.
Chart 1. New York State Life Sciences Venture Capital Funding.
Chart 2. New York Attracted Record NIH Funding in 2020.
Chart 3. Ratio of Private (VC) Investments to Public (NIH) Funding in Select States.
Chart 4. New York City Life Sciences Gross City Product.
Chart 5. New York City Life Sciences Employment.
___________________________________________________________________________________________